Target intelligence / Profile preview

Plasmodium falciparum mitochondrial membrane potential (MMP)

Target
MMP
Molecular classification
Other
01

Overview

The mitochondrial membrane potential (MMP) in Plasmodium falciparum is a critical electrochemical gradient generated by the mitochondrial electron transport chain (mETC) across the inner mitochondrial membrane (Mather et al., 2007). Unlike human mitochondria, which primarily utilize this gradient for ATP synthesis via oxidative phosphorylation, the malaria parasite relies on the mETC mainly to regenerate the ubiquinone pool (Painter et al., 2007). This pool is essential for the activity of dihydroorotate dehydrogenase (DHODH), a key enzyme in the de novo pyrimidine biosynthesis pathway required for DNA and RNA production (Biagini et al., 2006). Disruption of the mETC by antimalarial drugs, such as atovaquone, leads to the rapid collapse of the MMP (Srivastava et al., 1997). This collapse halts pyrimidine synthesis, ultimately leading to parasite death during the erythrocytic stage of infection (Mather et al., 2007). Because of its central role in parasite survival, the maintenance of MMP is a major focus of drug discovery, although it is a physiological state maintained by multiple enzymes rather than a single molecular target itself (Biagini et al., 2006).

Other names
Mitochondrial electrochemical gradientMitochondrial Delta-psi-mMitochondrial transmembrane potential
02

Mechanism of action

Inhibition of the mitochondrial electron transport chain (mETC) complexes, such as the Cytochrome bc1 complex, prevents proton pumping and leads to the dissipation of the electrochemical gradient (membrane potential), which is essential for the function of dihydroorotate dehydrogenase (DHODH) in pyrimidine biosynthesis (Mather et al., 2007; Painter et al., 2007).

03

Biological functions

Pyrimidine biosynthesisMetabolic homeostasisElectrochemical gradient maintenance
04

Disease associations

Infection
05

Safety considerations

Potential for host mitochondrial toxicity due to similarities between parasite and human electron transport chain components (Biagini et al., 2006)Rapid emergence of drug resistance through point mutations in the mitochondrial-encoded Cytochrome b gene (Kessl et al., 2007)
06

Interacting drugs

Atovaquone

4 more in the full profile.

07

Biomarkers

JC-1 (5,5',6,6'-tetrachloro-1,1',3,3'-tetraethylbenzimidazolylcarbocyanine iodide) fluorescence ratioRhodamine 123 accumulationMitoTracker Red CMXRos staining

Beyond the preview

Go deeper on Plasmodium falciparum mitochondrial membrane potential (MMP).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Plasmodium falciparum mitochondrial membrane potential (MMP).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call